KORRO BIO INC (KRRO) Stock Analyst Ratings
USA - NASDAQ:KRRO - US5009461089 - Common Stock
6.28 USD
+0.29 (+4.84%)
6.161 USD
-0.12 (-1.89%)
ChartMill assigns a Buy % Consensus number of 85% to KRRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 66.3. This target is 955.73% above the current price.
KRRO was analyzed by 15 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about KRRO.
In the previous month the buy percentage consensus was at a similar level.
KRRO was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-14 | Jones Trading | Downgrade | Buy -> Hold |
| 2025-11-13 | Chardan Capital | Downgrade | Buy -> Neutral |
| 2025-11-13 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2025-11-13 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-11-13 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-11-13 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-10-31 | Clear Street | Initiate | Buy |
| 2025-08-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-13 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-08-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-29 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-04-16 | Chardan Capital | Initiate | Buy |
| 2025-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-19 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-18 | Jones Trading | Initiate | Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-21 | Raymond James | Initiate | Strong Buy |
| 2024-10-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-19 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | William Blair | Initiate | Outperform |
| 2024-08-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
KORRO BIO INC / KRRO FAQ
Can you provide the average price target for KORRO BIO INC stock?
15 analysts have analysed KRRO and the average price target is 66.3 USD. This implies a price increase of 955.73% is expected in the next year compared to the current price of 6.28.
What is the consensus rating for KRRO stock?
The consensus rating for KORRO BIO INC (KRRO) is 85.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed KORRO BIO INC (KRRO)?
The number of analysts covering KORRO BIO INC (KRRO) is 15.